As one of the driver mutations in PDAC, the tumor suppressor p53 is affected by mutations in 50–75% of PDAC diseases, which can lead to either loss or gain of function and accordingly differentially affect the tumor [75,76]. The gene discussed is TP53; the disease is neoplasm.